DAFTAR PUSTAKA

1. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman

Tatalaksana Sindrom Koroner Akut. Edisi IV. Jakarta : PERKI. 2018.

2. National Heart Foundation of Australia. Economic Cost of Acute Coronary

Syndrome in Australia: The Cost to Individuals and Their Families.
Melbourne: National Heart Foundation of Australia, 2018.

3. Antoniades L, Christodoulides T, Georgiou P, Hadjilouca C, Christodoulou

E, Papasavas E, et al. Epidemiology of Acute Coronary Syndromes in the
Mediterranean Island of Cyprus (CYPACS Study, Cyprus Study of Acute
Coronary Syndromes). Hell J Cardiol. 2014;55(2):139–49.

4. Marceau A, Samson J-M, Laflamme N, Rinfret S. Short and Long-Term

Mortality After STEMI Versus Non-STEMI: a Systematic Review and
Meta-Analysis. J Am Coll Cardiol. 2013;61(10):E96.

5. Rilantono LI. 5 Rahasia Penyakit Kardiovaskular. Rahajoe AU, Karo-Karo

S, editors. Jakarta : Falkutas Kedokteran Univeristas Indonesia. 2012;138-
67.

6. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos
JA, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation
Myocardial Infarction. J Am Heart Assoc. 2013;127(4):e362–425.

7. Doost Hosseiny A, Moloi S, Chandrasekhar J, Farshid A. Mortality pattern

and cause of death in a long-term follow-up of patients with STEMI treated
with primary PCI. Open Heart. 2016;3(1):e000405.

8. Kip K, Hollabaugh K, Marroquin O, O Williams D. The Problem With

Composite End Points in Cardiovascular Studies. Vol. 51, J Am Coll
Cardiol. 2008;51(7):701-7.

9. Tsai I, Wang C, Lu Y, Hung W, Wu C, Lu L, et al. The burden of major

adverse cardiac events in patients with coronary artery disease. BMC
Cardiovasc Disord. 2017;17(1):1–13.

10. Martalena D, Nasution SA, Purnamasari D, Harimurti K. Pengaruh

Hiperglikemia Admisi terhadap Major Adverse Cardiac Events Selama
Perawatan pada Pasien Sindrom Koroner Akut di ICCU RSCM Jakarta.
eJKI. 2013;1(2):106–12.

11. Rampengan SH, Kalim H, Karo-Karo S, Soerianata S, Harimurti GM.

Myeloperoxidase as a Predictor for Subsequent Cardiovascular Events in
Patients with Acute Myocardial Infarction. JKI. 2007;28(4):267–78.

Fakultas Kedokteran Universitas Andalas 51

12. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP,
et al. Predictors of Hospital Mortality in the Global Registry of Acute
Coronary Events. Arch Intern Med. 2003;163:2345–53.

13. Rahmi PM. Kejadian Kardiovaskular Mayor Selama Rawatan Pada Infark
Miokard Akut Dengan Elevasi Segmen ST (IMA-EST) Di RSUP Dr. M.
Djamil Padang (Skripsi). Padang : Universitas Andalas. 2017.
http://scholar.unand.ac.id/25978/.

14. Arso IA, Setianto BY, Taufiq N, Hartopo AB. In-hospital Major
Cardiovascular Events between STEMI Receiving Thrombolysis Therapy
and Primary PCI. Acta Medica Indones. 2014;46(2):124–30.

15. Parhar K, Millar V, Zochios V, Bruton E, Jaworksi C, West N, et al.

Clinical outcomes of patients undergoing primary percutaneous coronary
intervention for acute myocardial infarction requiring the intensive care
unit. J Intensive Care. 2018;6(1):1–10.

16. Moeswir D. Skor Prediksi Major Adverse Cardiac Events Tujuh Hari Pada
Pasien Sindrom Koroner Akut (Tesis). Jakarta : Universitas Indonesia.
2014. http://lib.ui.ac.id/abstrakpdf?id=20391168&lokasi=lokal.

17. Vlodaver Z, Wilson RF, Garry DJ, editors. Coronary Heart Disease
Clinical, Pathological, Imaging, and Molecular Profiles. Minneapolis:
Springer Publishing; 2012.

18. Runge MS, Stouffer GA, Patterson C, editors. Netter’s Cardiology. 2nd ed.
Philadelphia: Elsevier Saunders. 2010.

19. Alwi I. Infark Miokard Akut dengan Elevasi ST. Dalam: Buku Ajar Ilmu
Penyakit Dalam Jilid II. Edisi VI. Jakarta : Interna Publishing. 2014;1459-
76.

20. Ward MJ, Kripalani S, Zhu Y, Alan B, Dittus RS, Harrell FE, et al.
Incidence of Emergency Department Visits for ST-Elevation Myocardial
Infarction in a Recent 6-Year Period in the United States. Am J Cardiol.
2016;115(2):167–70.

21. Kedev S, Kalpak O, Antov S, Kostov J, Pejkov H, Spiroski I. The

prevalence and outcomes of transradial percutaneous coronary intervention
for acute coronary syndrome. Analysis from the single-centre ISACS-TC
Registry (International Survey of Acute Coronary Syndrome in
Transitional Countries) (2010-12). EHJs. 2014;A33–A41.

22. Putra S, Elfi EF, Afdal. Gambaran Faktor Risiko dan Manajemen Reperfusi
Pasien IMA-EST di Bangsal Jantung RSUP Dr. M. Djamil Padang. JKA.
2017;6(3):621-6.

Fakultas Kedokteran Universitas Andalas 52

23. Pramadiaz AT, Fadil M, Mulyani H. Hubungan Faktor Risiko Terhadap
Kejadian Sindroma Koroner Akut pada Pasien Dewasa Muda di RSUP Dr.
M. Djamil Padang. JKA. 2016;5(2):330-7.

24. Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 9th ed.
Philadelphia: Elsevier Saunders. 2012.

25. Aziz M, Yadav K. Pathogenesis of Atherosclerosis A Review. Med Clin

Rev. 2016;2(3):1–6.

26. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H,

et al. 2017 ESC Guidelines for the management of acute myocardial
infarction in patients presenting with ST-segment elevation. Eur Heart J.
2018;39(2):119–77.

27. Zafari AM (19 Jul 2018). Myocardial Infraction. Medscape.

https://emedicine.medscape.com/article/155919 - Diakses 2 Januari 2019.

28. Samsu N, Sargowo D. Sensitivitas dan Spesifisitas Troponin T dan I pada

Diagnosis Infark Miokard Akut. MKI. 2007;57(10):363–72.

29. Sungkar MA. Elevation Myocard Infarct Acute Coronary Syndrome (

STEMI ACS ). Semarang: RS Roemani Muhammadiyah. 2017.

30. Firman D. Intervensi Koroner Perkutan Primer. JKI. 2010;31(2):112–7.

31. Piccolo R, Windecker S. Dual Antiplatelet Therapy in Percutaneous

Coronary Intervention: A Tale of 2 Decades With New Perspectives in the
Era of New-Generation Drug-Eluting Stents. Circ Cardiovasc Interv.
2016;9(2):1–4.

32. Mullasari AS, Balaji P, Khando T. Managing Complications in Acute

Myocardial Infarction. J Assoc Physicians India. 2011;59(12 SPEC.
ISSUE):43–8.

33. Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge
NL, et al. Standardized Definitions for Cardiovascular and Stroke Endpoint
Events in Clinical Trials. Draft Definitions for CDISC. 2014;1–33.

34. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al.
Fourth Universal Definition of Myocardial Infarction. J Am Coll Cardiol.
2018;25285.

35. Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT, Drozda JP, et
al. 2013 ACCF/AHA Key Data Elements and Definitions for Measuring
the Clinical Management and Outcomes of Patients With Acute Coronary
Syndromes and Coronary Artery Disease. J Am Coll Cardiol.
2013;61(9):992–1025.

Fakultas Kedokteran Universitas Andalas 53

36. Truelsen T, Begg S, Mathers C. The global burden of cerebrovascular
disease. Glob Burd Dis. 2005;1–67.

37. Stouffer GA (12 Oktober 2016). Percutaneous Coronary Intervention

(PCI). Medscape. https://emedicine.medscape.com/article/161446 -
Diakses 6 Januari 2019.

38. Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, et
al. Repeat Revascularization After Contemporary Percutaneous Coronary
Intervention. Circ Cardiovasc Interv. 2012;5(6):772–82.

39. Bauer T, Zeymer U. Impact of age on outcomes of percutaneous coronary

intervention in acute coronary syndromes patients. Interv Cardiol.
2010;2(3):319–25.

40. Guo Y, Yin F, Fan C, Wang Z. Gender difference in clinical outcomes of

the patients with coronary artery disease after percutaneous coronary
intervention: A systematic review and meta-analysis. Medicine
(Baltimore). 2018;97(30):e11644.

41. Norman A, Zaman AG, Schechter C, Balasubramaniam K, Das R. Early

discharge after primary percutaneous coronary intervention for ST-
elevation myocardial infraction. European Heart Journal: Acute
Cardiovascular Care.2013;2(3):262–269.

42. Wang R, Mei B, Liao X, Lu X, Yan L, Lin M, et al. Determination of risk

factors affecting the in-hospital prognosis of patients with acute ST
segment elevation myocardial infraction after percutaneous coronary
intervention. BMC Cardiovasc Disord. 2017;17(1):1–11.

43. Lee JH, Park HS, Chae SC, Cho Y, Yang DH, jeong MH, et al. Predictors
of Six-Month Major Adverse Cardiac Events in 30-Day Survivors After
Acute Myocardial Infraction (from the Korea Acute Myocardial Infraction
Registry). Am J Cardiol. 2009;104(2):182-9.

44. Kim C, Chang HJ, Cho I, Sung JM, Choi D, Jeong MH, et al. Impact of
family history on the presentation and clinical outcomes of coronary heart
disease: data from the Korea Acute Myocardial Infarction Registry. Korean
J Intern Med. 2013 Sep 14;28(5):547–56.

45. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, et
al. Family History of Premature Coronary Heart Disease and Coronary
Artery Calcification. Circulation. 2007 Aug 7;116(6):619–26.

46. Lu X, Wang Y, Meng H, Chen P, Huang Y, Wang Z, et al. Association of

admission serum calcium levels and in-hospital mortality in patients with
acute ST-elevated myocardial infarction: an eight-year, single-center study
in China. PLoS One. 2014;9(6):e99895.

Fakultas Kedokteran Universitas Andalas 54

47. Thune JJ, Signorovitch J, Kober L, Velazquez EJ, Mcmurray JJ V., Califf
RM, et al. Effect of Antecedent Hypertension and Follow-Up Blood
Pressure on Outcomes After High-Risk Myocardial Infarction.
Hypertension. 2008;51(1):48–54.

48. Jensen LO, Maeng M, Thayssen P, Tilsted HH, Terkelsen CJ, Kaltoft A, et
al. Influence of Diabetes Mellitus on Clinical Outcomes Following Primary
Percutaneous Coronary Intervention in Patients With ST-Segment
Elevation Myocardial Infarction. Am J Cardiol. 2012;109(5):629–35.

49. Lee MG, Jeong MH, Lee KH, Park KH, Sim DS, Yoon HJ, et al.
Prognostic impact of diabetes mellitus and hypertension for mid-term
outcome of patients with acute myocardial infarction who underwent
percutaneous coronary intervention. J Cardiol. 2012;60(4):257–63.

50. Mohamedali B, Shroff A. Impact of Smoking Status on Cardiovascular

Outcomes Following Percutaneous Coronary Intervention. Clin Cardiol.
2013;36(7):372–7.

51. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety

of more intensive lowering of LDL cholesterol: a meta-analysis of data
from 170000 participants in 26 randomised trials. Lancet. 2010;376:1670-
81.

52. Shlomai G, Kopel E, Goldenberg I, Grossman E. The association between

elevated admission systolic blood pressure in patients with acute coronary
syndrome and favorable early and late outcomes. J Am Soc Hypertens.
2015;9(2):97–103.

53. Hall JE, Guyton AC. Guyton dan Hall Buku Ajar Fisiologi Kedokteran.
12th ed. Singapura: Elsevier. 2011.

54. Putri VU. Tekanan Darah Sistolik dan Denyut Jantung Sebagai Prediktor
Major adverse Cardiac Events Pada Sindroma Koroner Akut. Jakarta :
Universitas Islam Negeri Syarif Hidayatullah. 2014.

55. Sabatine MS, Morrow DA, Giugliano RP, Burton PBJ, Murphy SA,
McCabe CH, et al. Association of Hemoglobin Levels With Clinical
Outcomes in Acute Coronary Syndromes. Circulation. 2005;111(16):2042–
9.

56. Buber J, Laish-farkash A, Koren-morag N, Fefer P. Cardiac troponin

elevation pattern in patients undergoing a primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction :
characterization and relationship with cardiovascular events during
hospitalization. 2015;16(6):503–9.

Fakultas Kedokteran Universitas Andalas 55

57. Vinod P, Kann T, Polaconda S, Bello A, Khayata M, Munoz F, et al.. The
Impact of Admission Serum Creatinine on Major Adverse Clinical Events
in ST-Segment Elevation Myocardial Infarction Patients Undergoing
Primary Percutaneous Coronary Intervention. Cardiol Res. 2018;9(2):94–8.

58. Horiuchi Y, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, et al. A High

Level of Blood Urea Nitrogen Is a Significant Predictor for In-hospital
Mortality in Patients with Acute Myocardial Infarction. Int Heart J.
2018;59(2):263–71.

59. Ryu KS, Park HW, Park SH, Shon HS, Ryu KH, Lee DG, et al.
Comparison of clinical outcomes between culprit vessel only and
multivessel percutaneous coronary intervention for ST-segment elevation
myocardial infarction patients with multivessel coronary diseases. J Geriatr
Cardiol. 2015;12(3):208–17.

60. Sorajja P, Gersh BJ, Cox DA, Mclaughlin MG, Zimetbaum P, Costantini
C, et al. Impact of multivessel disease on reperfusion success and clinical
outcomes in patients undergoing primary percutaneous coronary
intervention for acute myocardial infarction. Eur Heart J.
2007;28(14):1709–16.

61. Song JX, Zhu L, Lee CY, Ren H, Cao CF, Chen H. Total ischemic time
and outcomes for patients with ST-elevation myocardial infarction: Does
time of admission make a difference?. J Geriatr Cardiol. 2016;13(8):658–
64.

62. Dahlan MS. Besar Sampel dalam Penelitian Kedokteran dan Kesehatan. 4th
ed. Jakarta: Epidemiologi Indonesia. 2016.

63. Oktavia P. Gambaran Kejadian Kardiovaskular Mayor Dalam 6 Bulan

Pasca Rawatan Pada Infark Miokard Akut Dengan Elevasi Segmen ST
(IMA-EST) Yang Menjalani Reperfusi Di RSUP Dr. M. Djamil Padang
(Skripsi). Padang : Universitas Andalas. 2018.

64. Third Report of the National Cholesterol Education Program (NCEP)

Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) Final Report. 2002;II-19.

65. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL,
et al. The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure. JAMA.
2003;289(19):12–4.

66. American Diabetes Association. Standards of Medical Care in Diabetes-

2018. Diabetes Care. 2018 Jan;41(Supplement 1):S1-159.

Fakultas Kedokteran Universitas Andalas 56

67. Adam JM. Dislipidemia. Dalam: Buku Ajar Ilmu Penyakit Dalam Jilid II.
Edisi VI. Jakarta : Interna Publishing. 2014;2551-7.

68. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, Lemos
JA De, et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A
Convenient, Bedside, Clinical Score for Risk Assessment at Presentation.
Circulation. 2000;102(17):2031–7.

69. WHO. Haemoglobin concentrations for the diagnosis of anaemia and

assessment of severity. Vitamin and Mineral Nutrition Information System.
Geneva, World Health Organization. 2011.
https://www.who.int/vmnis/indicators/haemoglobin.pdf - Diakses Maret
2019.

70. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et
al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary
Intervention: A Report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice Guidelines
and the Society for Cardiovascular Angiography and Interventions. J Am
Coll Cardiol. 2011;58(24):e44-122.

71. Swaminathan RV, Rao SV, McCoy LA, Kim LK, Minutello RM, Wong
SC, et al. Hospital Length of Stay and Clinical Outcomes in Older STEMI
Patients After Primary PCI. J Am Coll Cardiol. 2015;65(12):1161-71.

72. Merz CNB, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, et al.
Insights From the NHLBI-Sponsored Women s Ischemia Syndrome
Evaluation ( WISE ) Study. J Am Coll Cardiol. 2006;47:21S–9S.

73. Xu L, Yu C, Jiang J, Zheng H, Yao S, Pei L, et al. Major adverse cardiac

events in elderly patients with coronary artery disease undergoing
noncardiac surgery: A multicenter prospective study in China. Arch
Gerontol Geriatr. 2015;61(3):503–9.

74. Nash MC, Strom JA, Pathak EB. Prevalence of major infections and
adverse outcomes among hospitalized . ST-elevation myocardial infarction
patients in Florida , 2006. BMC Cardiovasc Disord. 2011;11(1):69.

75. Musher DM, Rueda AM, Kaka AS, Mapara SM. The Association between
Pneumococcal Pneumonia and Acute Cardiac Events. Clin Infect Dis.
2007;45(2):158-65.

76. Giacoppo D, Madhavan MV, Baber U, Warren J, Bansilal S, Witzenbichler

B, et al. Impact of Contrast-Induced Acute Kidney Injury After
Percutaneous Coronary Intervention on Short- and Long-Term Outcomes.
Circ Cardiovasc Interv. 2015;8(8):1-9

Fakultas Kedokteran Universitas Andalas 57

77. El-Menyar A, Zubaid M, AlMahmeed W, Sulaiman K, AlNabti A, Singh
R, et al. Killip classification in patients with acute coronary syndrome :
insight from a multicenter registry. Am J Emerg Med. 2012;30(1):97–103.

78. Pitsavos C, Panagiotakos D, Zombolos S, Mantas Y, Antonoulas A,

Stravopodis P, et al. Systolic Blood Pressure on Admission Predicts In-
Hospital Mortality Among Patients Presenting With Acute Coronary
Syndromes : The Greek Study of Acute Coronary Syndromes. J Clin
Hypertens. 2008;10(5):362–366.

79. Tanjung SA, Faktor-Faktor Yang Mempengaruhi Kejadian Kardiovaskular

Mayor Pada Pasien Infark Miokard Akut Di RSUP Haji Adam Malik
Medan (Skripsi). Medan : Universitas Sumatera Utara. 2017.

80. Cediel G, Rueda F, Garcia C, Oliveras T, Labata C, Serra J, et al.

Prognostic Value of New‐Generation Troponins in ST‐Segment–Elevation
Myocardial Infarction in the Modern Era The RUTI‐STEMI Study. J Am
Heart Assoc. 2017;6:e007252.

81. Hall TS, Hallén J, Krucoff MW, Roe MT, Brennan DM, Agewall S, et al.
Cardiac troponin I for prediction of clinical outcomes and cardiac function
through 3-month follow-up after primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction. Am Heart J.
2015;169(2):257-265.

82. Hallén J. Troponin for the Estimation of Infarct Size : What Have We
Learned?. Cardiology. 2012;204–12.

83. Ahmed F, Rahman A, Rahman MA, Chowdhury TA, Chowdhury MSH,

Uddin SN, et al. Predictors of Short Term Outcomes of Primary
Percutaneous Coronary Intervention. Bangladesh Heart Journal.
2018;33(2):112-120.

84. Luca GD, Suryapranata H, Ottervanger JP, Antman EM. Time Delay to
Treatment and Mortality in Primary Angioplasty for Acute Myocardial
Infarction Every Minute of Delay Counts. 2004;1223–5.

85. Sanidas EA, Brener SJ, Maehara A, Genereux P, Witzenbichler B, El-Omar

M, et al. Outcomes in Diabetic Patients Undergoing Primary Percutaneous
Coronary Intervention for Acute Anterior Myocardial Infarction: Results
From the INFUSE-AMI Study. Catheter Cardiovasc Interv.
2014;83(5):704–10.

86. Viikilä J, Nieminen T, Tierala I, Laine M. Safety of the primary

percutaneous coronary intervention strategy combining pre-hospital
prasugrel , enoxaparin and in-hospital bivalirudin in acute ST-segment
elevation myocardial infarction. BMC Cardiovasc Disord. 2016;1–6.

Fakultas Kedokteran Universitas Andalas 58

87. Ciccarelli G, Barbato E, Golino M, Cimmino G, Bartunek J, Serafino LD,
et al. Prognostic Factors in Patients With Stemi Undergoing Primary PCI in
the Clopidogrel Era : Role of Dual Antiplatelet Therapy at Admission and
the Smoking Paradox on Long-Term Outcome. J Interven Cardiol.
2017;30(1):5–15.

Fakultas Kedokteran Universitas Andalas 59